Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia.
IgM monoclonal gammopathy
IgM-related disorders
IgM-secreting multiple myeloma
Waldenström macroglobulinemia
Journal
Hematological oncology
ISSN: 1099-1069
Titre abrégé: Hematol Oncol
Pays: England
ID NLM: 8307268
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
18
06
2018
revised:
12
07
2018
accepted:
12
07
2018
pubmed:
8
9
2018
medline:
8
5
2019
entrez:
8
9
2018
Statut:
ppublish
Résumé
The finding of an IgM monoclonal gammopathy often represents a diagnostic challenge. In fact, there are many pathological disorders associated with this condition, each of which has distinctive characteristics and requires specific clinical, instrumental, and laboratory assessments to set the appropriate treatment. This review has two aims. Firstly, to provide a framework of the broad spectrum of IgM-associated disorders: (1) monoclonal gammopathy of undetermined significance (MGUS); (2) Waldenström macroglobulinemia (WM); (3) IgM-related disorders (among which hyperviscosity syndrome, light chain amyloidosis, cold agglutinin disease, cryoglobulinaemia, IgM neuropathy, Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, skin changes (POEMS) syndrome, Castleman disease); (4) IgM-secreting multiple myeloma (IgM-MM); and (5) other lymphoproliferative disorders which may be associated with IgM (such as chronic lymphocytic leukemia, small lymphocytic lymphoma, and B-cell non Hodgkin lymphoma). Secondly, to give a detailed insight regarding diagnosis and treatment of WM.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
117-128Informations de copyright
© 2018 John Wiley & Sons, Ltd.